A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

This publication has 13 references indexed in Scilit:

• Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Original article: Prognostic factors in hormone-resistant progressing cancer of the prostate
  Annals of Oncology, 1992
• A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain
  Radiotherapy and Oncology, 1992
• Strontium-89 chloride for pain palliation in prostatic skeletal malignancy
  The British Journal of Radiology, 1991
• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991
• Phosphorus-32 for intractable bony pain from carcinoma of the prostate
  Clinical Oncology, 1990
• Half-body Irradiation for Treatment of Widely Metastatic Adenocarcinoma of the Prostate
  Journal of Urology, 1989
• Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
  European Journal of Nuclear Medicine and Molecular Imaging, 1986
• Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases
  Radiotherapy and Oncology, 1986
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958